Ocera Therapeutics Highlights OCR-002 Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
05 oct. 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...
Ocera Initiates Phase 1 Clinical Trial of Oral Drug Candidate OCR-002 for Prevention of Hepatic Encephalopathy
16 sept. 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Sept. 16, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...
Ocera to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
01 sept. 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Sept. 01, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...
Ocera Therapeutics Reports Second Quarter 2015 Financial Results
03 août 2015 16h13 HE
|
Ocera Therapeutics, Inc.
Continued Strong Enrollment in STOP-HE On Track for Initiation of Phase 1 Trial with Oral Formulation of OCR-002 in Third Quarter $20 Million Debt Facility Extends Cash Resources to Mid-2017 PALO...
Ocera Therapeutics Secures $20 Million Debt Facility from Oxford Finance and Silicon Valley Bank
30 juil. 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., July 30, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...
Medical Marijuana, Inc.'s Video Statement on Investment Portfolio's Historic Accomplishments and Supporting the Science Behind Cannabis Legalization
15 juil. 2015 10h15 HE
|
Medical Marijuana Inc
SAN DIEGO, July 15, 2015 (GLOBE NEWSWIRE) -- "Honestly, if you and I would have sat here two or three years ago, people would be saying, 'I would never invest in marijuana stocks,'" states Andrew...
Ocera Therapeutics to Present at the JMP Securities Life Sciences Conference
16 juin 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Therapeutics to Present at the Jefferies 2015 Healthcare Conference
29 mai 2015 13h30 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., May 29, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera CEO to be Honored at the 17th Annual American Liver Foundation's Salute to Excellence Awards Gala in San Francisco
04 mai 2015 08h35 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., May 4, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Therapeutics Announces Change in Executive Team
04 mai 2015 08h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., May 4, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), today announced that Rajiv Patni, M.D., chief development officer, has decided to step down from his position...